SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-13-005463
Filing Date
2013-09-30
Accepted
2013-09-30 16:55:26
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12013_actiniumpharma.htm S-1 3795090
2 TRANSACTION MANAGEMENT AGREEMENT fs12013ex10xxxi_actinium.htm EX-10.31 109340
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs12013ex23i_actiniumpharma.htm EX-23.1 3607
10 img001.jpg GRAPHIC 8012
  Complete submission text file 0001213900-13-005463.txt   11986300

Data Files

Seq Description Document Type Size
4 fil-20130630.xml EX-101.INS 1576926
5 fil-20130630.xsd EX-101.SCH 85613
6 fil-20130630_cal.xml EX-101.CAL 42447
7 fil-20130630_def.xml EX-101.DEF 282223
8 fil-20130630_lab.xml EX-101.LAB 606750
9 fil-20130630_pre.xml EX-101.PRE 417145
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-191468 | Film No.: 131123900
SIC: 6770 Blank Checks